Bay­er, Astel­las gear up for next CEOs; Ex-AM­AG chief Scott My­ers resur­faces at Virid­i­an

→ You know how we told you last week that we’d keep our eyes peeled for where ex-Roche Phar­ma­ceu­ti­cals CEO Bill An­der­son turns up next? Well, he gave us an an­swer in a big way.

An­der­son will be the CEO at Bay­er start­ing April 1, the Ger­man phar­ma said Wednes­day. Un­like Roche, Mer­ck, J&J and the CEO tran­si­tion that fol­lows, Bay­er chose not to go in-house for Wern­er Bau­mann’s re­place­ment. In­vestors have been grum­bling about the com­pa­ny’s stock per­for­mance, so much so that ac­tivist in­vestor Jeff Ubben ral­lied the troops to find some­one out­side the com­pa­ny to take con­trol. In the end, the in­vestors won.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.